levodopa has been researched along with Gaucher Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, J; Artuch, R; Darling, A; De Oryazábal Sanz, AL; Díaz-Conradi, Á; García-Cazorla, À; Giraldo, P; Gort, L; Irún, P; O'Callaghan, M; Ormazábal, A; Yubero, D | 1 |
| Bembi, B; LaMarca, ME; Orvisky, E; Rosenbaum, H; Schiffmann, R; Sidransky, E; Stubblefield, B; Tayebi, N; Walker, J; Wong, K | 1 |
| Bembi, B; Capus, L; Carrozzi, M; Ciana, G; Gioulis, M; Martini, C; Pittis, MG; Sidransky, E; Zambito Marsala, S; Zorzon, M | 1 |
3 other study(ies) available for levodopa and Gaucher Disease
| Article | Year |
|---|---|
Pediatric Gaucher disease with intermediate type 2-3 phenotype associated with parkinsonian features and levodopa responsiveness.
Topics: Antiparkinson Agents; Child, Preschool; Diseases in Twins; Female; Gaucher Disease; Humans; Infant; Levodopa; Male; Parkinsonian Disorders; Phenotype; Twins | 2021 |
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
Topics: Adult; Blotting, Southern; Brain; Deoxyribonucleases, Type II Site-Specific; Female; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Homozygote; Humans; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Psychosine; Sphingosine | 2003 |
Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
Topics: Adult; Age of Onset; Aged; Anemia; Antiparkinson Agents; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Gaucher Disease; Glucosylceramidase; Hepatomegaly; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Recombinant Proteins; Siblings; Splenomegaly; Thrombocytopenia; Tremor | 2003 |